Shopping Cart
Remove All
Your shopping cart is currently empty
Keap1-Nrf2-IN-11
Copy Product Info
😃Good
Catalog No. T72687Cas No. 2796292-75-4
Keap1-Nrf2-IN-11 (Compound 6k), a potent Keap1-Nrf2 inhibitor, exhibits a dissociation constant (KD) of 0.21 nM. It hampers the production of reactive oxygen species (ROS) and nitric oxide (NO), as well as the expression of tumor necrosis factor-alpha (TNF-α). By promoting Nrf2 nuclear translocation, it mitigates inflammation and is utilized in anti-inflammatory studies [1].
Keap1-Nrf2-IN-11
Copy Product Info😃Good
Catalog No. T72687Cas No. 2796292-75-4
Keap1-Nrf2-IN-11 (Compound 6k), a potent Keap1-Nrf2 inhibitor, exhibits a dissociation constant (KD) of 0.21 nM. It hampers the production of reactive oxygen species (ROS) and nitric oxide (NO), as well as the expression of tumor necrosis factor-alpha (TNF-α). By promoting Nrf2 nuclear translocation, it mitigates inflammation and is utilized in anti-inflammatory studies [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Resource Download
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | Keap1-Nrf2-IN-11 (Compound 6k), a potent Keap1-Nrf2 inhibitor, exhibits a dissociation constant (KD) of 0.21 nM. It hampers the production of reactive oxygen species (ROS) and nitric oxide (NO), as well as the expression of tumor necrosis factor-alpha (TNF-α). By promoting Nrf2 nuclear translocation, it mitigates inflammation and is utilized in anti-inflammatory studies [1]. |
| In vitro | Keap1-Nrf2-IN-11 (compound 6k) at 10 μΜ significantly inhibits ROS and NO production and reduces proinflammatory cytokine TNF-α levels in an LPS-induced murine peritoneal macrophage model [1]. |
| In vivo | Keap1-Nrf2-IN-11 (compound 6k) demonstrates anti-inflammatory effects in vivo at dosages of 5-10 mg/kg when administered intraperitoneally in an ALI mouse model. Pharmacokinetic parameters in SD rats, following a 5 mg/kg intravenous dose, show a half-life (T1/2) of 4.31 hours, clearance (CL) of 5.57 mL/min/kg, and an apparent distribution volume (V) of 959 L/kg. In the ALI mouse model with a 5 mg/kg intraperitoneal dose, compound 6k presents a half-life (T1/2) of 10.92 hours, a maximum plasma concentration (Cmax) of 707 ng/mL, an area under the curve (AUC) of 3702 ng•h/mL, and an oral bioavailability (F) of 19.86%. |
| Molecular Weight | 765.9 |
| Formula | C36H43N7O8S2 |
| Cas No. | 2796292-75-4 |
| Smiles | CCN1CCN(CC1)CCC(=O)NC2=CC=C(C=C2)S(=O)(=O)N(CC(=O)N)C3=CC=C(C4=CC=CC=C43)N(CC(=O)N)S(=O)(=O)C5=CC=C(C=C5)OC |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Keap1-Nrf2-IN-11 | purchase Keap1-Nrf2-IN-11 | Keap1-Nrf2-IN-11 cost | order Keap1-Nrf2-IN-11 | Keap1-Nrf2-IN-11 chemical structure | Keap1-Nrf2-IN-11 in vivo | Keap1-Nrf2-IN-11 in vitro | Keap1-Nrf2-IN-11 formula | Keap1-Nrf2-IN-11 molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.